Study summary · research use only
[Immune mechanisms of hepatoprotector effects of etomersol and thymogen]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
Species not specified in this study of the reparation-regeneration properties of the actoprotector etomerzol and the immunomodulator thymogen, examined after thymectomy, hepatectomy, or their combination. The authors reported that both agents lost their hepatoprotector activity after thymectomy but still stimulated antibody-forming cell production in the spleen in response to the stressor procedures. The authors describe etomerzol as having a dominant immunomodulant activity, based on this pattern and its lack of influence on the immune state of intact animals.
Abstract
The reparation-regeneration effects of the actoprotector etomerzol and the immunomodulant thymogen can be mediated by certain units of the immune system, in particular, by thymus. Both thymogen and etomerzol loss the hepatoprotector activity on the background of thymectomy, but still produce an immunomodulant effect by stimulating the production of antibody-forming cells in the spleen in response to changes in the immune system induced by various stressor factors (thymectomy, hepatectomy, or their combination). This property of etomerzol, together with the absence of influence upon the immune state of intact experimental animals, is evidence of a dominating immunomodulant activity of this drug.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.